Research data · Disease model and test
Novel object recognition in substance use disorders research
From 2021 to 2025, 38 animal research papers on substance use disorders mentioned novel object recognition in their title or abstract.
That is 2.1 times the 18 papers of 2011 to 2015. Between the same two periods, the papers on substance use disorders that mention any of the 90 tests we count fell 12%.
Papers by year
Animal research papers on substance use disorders that mention novel object recognition, by year, 2001 to 2026
The 2026 bar counts papers added to PubMed by November 8, 2026.
- Papers in a full year
- 2026 so far
Show the counts for each year
| Year | Papers |
|---|---|
| 2001 | 0 |
| 2002 | 2 |
| 2003 | 0 |
| 2004 | 1 |
| 2005 | 0 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 8 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 3 |
| 2018 | 9 |
| 2019 | 5 |
| 2020 | 12 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 5 |
| 2026 (part year) | 9 |
Which species the papers used
Each bar is a share of the 38 papers from 2021 to 2025. A paper can use more than one species, so the shares can add to more than 100%.
Species
Tests mentioned alongside novel object recognition
Each bar is one test, with how many of the 38 papers also mention it, and what share that is. Of these papers, 6 (16%) mention no other test.
The 12 tests these papers mention most
Which papers count
A paper counts here when it is animal research, mentions novel object recognition in its title or abstract, and studies substance use disorders.
We tell whether a paper studies substance use disorders from its MeSH terms, the subject headings the National Library of Medicine adds when it indexes a paper. For a paper without MeSH terms, PubTator 3, NCBI's text-mining service, has to find the disease in the title or abstract. A paper can count under more than one disease model. A paper that mentions the test only in its methods is missed, so the count runs low.
The page on substance use disorders research names the subject headings we count as substance use disorders. Download the test list for the search terms we used for novel object recognition, or the paper list for the PubMed ID of every paper behind these counts. Our main page, Behavioral tests in published research, has the full method and each source's terms of use.
More tests and disease models
Every pairing of a disease model and a test with 30 or more papers from 2021 to 2025 has a page like this one.
Papers on substance use disorders that mention other tests
Papers on other disease models that mention novel object recognition
- Cognitive impairment and dementia 1,400 papers
- Alzheimer disease 568 papers
- Anxiety 286 papers
- Depression 134 papers
- Stroke and brain ischemia 133 papers
- Brain injury 116 papers
- Aging 107 papers
- Epilepsy and seizures 98 papers
- Schizophrenia and psychosis 96 papers
- Diabetes 91 papers
- Obesity and high-fat diet 90 papers
- Psychological stress 77 papers
- Autism spectrum disorder 53 papers
- Parkinson disease 51 papers
- Pain conditions 42 papers
- Sleep loss and sleep disorders 40 papers
The page on novel object recognition counts all the papers that mention it, whatever they study. The page on substance use disorders research ranks the tests by their papers on substance use disorders.
How to cite
APA
ConductScience. (2026, November 10). Novel object recognition in substance use disorders research [Data set]. https://conductscience.com/data/behavioral-tests/models/substance-use/novel-object-recognition
BibTeX
@misc{conductscience_substance_use_novel_object_recognition_2026,
author = {{ConductScience}},
title = {Novel object recognition in substance use disorders research},
year = {2026},
month = nov,
url = {https://conductscience.com/data/behavioral-tests/models/substance-use/novel-object-recognition},
note = {Data set, released November 10, 2026},
}Novel object recognition apparatus in our store
In the test battery tool, pick every test your study will run and add the apparatus for all of them to one quote.
